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Abstract— Glucose monitoring technology has been used by  
diabetic patients to monitor their blood glucose level for the past 
three decades. This technology is very useful for managing diet 
among diabetic patients. This paper reviews the fundamental 
technique of blood glucose detection method and the development 
of blood glucose monitoring systems that have been developed ever 
since. The most common and widely used technique is an invasive 
technique that requires users to prick their finger to draw the 
blood. However, recently a lot of new technologies have been 
developed for non-invasive technique to monitor blood glucose 
monitoring and studies in this area are growing rapidly. Among 
all, the optical and transdermal approach are the two most 
potential sensing modalities for non-invasive glucose monitoring 
that show a very good prospect. 
 
Index Terms— Blood glucose, Personal-monitoring, Invasive 




Blood glucose monitoring device is used to monitor the blood 
glucose concentration level. Normally, such device is used by 
diabetic patients to monitor the blood glucose level throughout 
the day in order to help them to understand the behaviour of the 
blood concentration based on the food intake and activity [1, 2]. 
Commonly, blood glucose reading is taken by using a glucose 
meter as can be seen in Figure 1. In order to do this test, it 
requires user to draw their blood and apply it to the test-strip. 
This test strip needs to be inserted into the glucose meter to get 
the reading. Basically, this typical glucose meter is produced by 
several different manufacturers with a similar approach where 
in most systems, it measures the electrical characteristic of the 
voltage output from the biosensor or test-strip that goes through 
a filter mechanism in order to improve the signal for a better 
voltage to blood glucose concentration conversion.  
Normally, the diabetes patients are advised to have an 
appropriate blood glucose monitoring regime in order to keep 
track on their glucose level. This information will be very 
helpful for their physician to recommend the right dosage of 
insulin intake. The diabetes patients are suggested to test their 
blood glucose level at approximately three to seven times a day 




Figure 1: Finger puncturing and blood test using a glucose meter. 
 
















Figure 2: Overview of glucose measurement techniques. 
 
Generally, the method of measuring blood glucose 
concentration can be divided into three major approaches which 
are invasive, non-invasive and minimally invasive or also 
known as interstitial. The invasive method will require a draw 
of blood sample by puncturing a finger using needles or 
syringes. This blood sample then will be transferred to the blood 
glucose measurement device to measure the glucose 
concentration. For partially invasive method, it requires an 
insertion of the sensor into the skin while taking a reading of 
glucose concentration. The invasive approach is the most 
commonly used by patients because the approach uses a device 
cheaper than the device used by the partially invasive and non-
invasive approach. However, the invasive approach is not the 
best option for frequent blood glucose reading or continuous 
measurement since it causes discomfort to the patients every 
time when they take a reading. Therefore, minimally invasive 
and non-invasive methods are gaining their popularity for 
continuous monitoring of blood glucose concentration. These 
two methods offer many advantages over the invasive method: 
For instance, no blood sample is required for this test [4]. As 
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can be seen in Figure 2, for the non-invasive approach, the 
measurement is taken indirectly from the deposited of the 
excretory system such as urine, sweat, tears and etc. 
Figure 3 shows the chronology of the blood glucose 
monitoring systems since its first generation when it was first 
introduced in the 70s [3, 4]. The developments undertake to 
improve the way of measuring the blood glucose depend on 
several parameters such as the reading accuracy, techniques and 
approach, size of the device, and technology of the embedded 






















Figure 3: The graph of development of glucose monitoring. 
 
A. First Generation (Invasive) 
Anton Hubert (Tom) Clemens is an inventor of Ames 
Reflectance Meter (see Figure 4), the first blood glucose meter 
that had been patented in 1971 [4]. This glucose meter uses an 
enzyme test strip where the blood drop needs to be applied onto 
it and then washed away after the reading is taken. The blood 
glucose concentration will vary depending on the colour that 
will be read by the meter [5]. At the time when it was 
introduced, this instrument was expensive, relatively large in 
size and very heavy (approximately 1 kg). To use this device, it 
requires a relatively big amount of blood to be placed in the 
sensor area approximately 3/8 inch x 1/4 inch. The blood 
placement needs to be washed every time the blood glucose 
reading was taken, causing this device to be more suitable to be 
used in the hospital by the physicians rather than for personal 
home usage. This device became the reference design for 
subsequent reflectance colorimeters such as Eyetone 
(introduced in 1972) and the Ames Glucometer (introduced in 
1971) [5, 6]. 
In 1975, Yellow Spring Instrument commercialised the 
YSI 23 model of glucose analyser based on the enzyme 
catalysed process glucose detection method developed by Clark 
and Lyons since 1962 [7]. This device utilized the oxidation of 
glucose, and subsequently the oxidation of the hydrogen 
peroxide that is formed during the initial response by glucose 
oxidase and enzyme horseradish peroxidase respectively [7]. In 
order to do the readings, this device requires only 25 µL of the 
whole blood sample, yet it was able to improve the detection 
accuracy in comparison to Ames reflectance meter [8]. Despite 
of being a stationary model linked to the doctor’s office, this 
sensor technology had become the basis for the state-of-the-art 
handheld devices of the second generation device, especially 
for home monitoring with an increasing amount of new 
products entering the market every year [5, 6]. 
 
 
Figure 4: Ames Reflectance Meter. 
 
B. Second Generation (Invasive) 
The ExacTech® strip is the first commercialised blood 
glucose meter for home application produced by MediSense 
(later it became part Abbott Laboratories) in 1987 [9]. This 
technology is based on the enzyme biosensor technology of 
Clark and Lyons as it utilizes an integrated electrochemical 
ferrocene-derivative mediator as an electron acceptor in 
contrast to the oxidation used in the earlier sensors [7, 10-12]. 
There is a lot of improvements that have been done to this 
device in terms of glucose reading accuracy, size and as well as 
its functionality for every version that has been released until 
now. This method of technology is still being used widely and 
it is run by several brands such as OneTouch by Lifescan and 
Nova Max Plus by NovaBiomedic. Examples of these glucose 
meters are presented in Figure 5 [13]. User needs to spend some 
money to buy the test strip because it is disposable and it comes 
with an expiration date [14]. 
 
 
Figure 5: The glucose meter in 21st century. 
 
C. Third Generation (minimally invasive and continuous) 
The third generation of the glucose monitoring system is more 
toward continuous monitoring. This monitoring technology is 
possible due to the development of a suitable sensor that can be 
inserted underneath a skin and can be left there for a week 
without requiring a draw of blood. The Medtronic MiniMed 
Company has been producing the first device of continuous 
glucose monitoring (CGM) system and this device has been 
approved by the American Food and Drug Administration 
(USFDA) in June 1991 [15]. Table 1 shows that there are only 
several types of commercially available CGM device approved 
by the USFDA or carry the European Commission (CE 
marking) for Europe market since the beginning of the twenty-
first century. This personal CGM device is typically used by 
diabetes patients and pregnant mothers with gestational 
diabetes symptoms with the recommendation of their physician 
[16]. Some of personal CGM devices are available with alarms 
that indicate changes of glucose levels in blood using a marker 
or trend arrows, and some are equipped with predictive alarms, 
which can estimate whether the glucose threshold would be 
crossed based on the current value of glucose concentration and 
its rate of changes [17]. A personal CGM device is normally 
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owned by a patient. The patient can monitor their glucose level 
continuously every minute by using this system [18]. This 
CGM device can be used together with insulin pump where the 
whole systems are able to function like pancreases in the body. 
The insulin will be released into the blood circulation with the 
right dosage required by the body. This system is able to give a 
real-time glucose result that allows for immediate and 
continuous therapeutic adjustments on the insulin intake [13]. 
In this method, a nano-needle at the glucose sensor electrode is 
inserted under the skin to measure the glucose concentration 
levels in the tissue as shown in Figure 6. 
 
 









(Northridge, CA) Guardian Telemetered Glucose 
Monitoring System and Guardian RT 
GlucoWatch Biographer Cygnus, Inc., (Redwood 
City, CA) 
GlucoDay-S A. Menarini Diagnostics, 
(Florence, Italy) 
Dexcom Seven Plus Dexcom (San Diego, CA) 
FreeStyle Navigator Abbott Diabetes Care 
(Alameda, CA) 
 
D. Fourth generation (Non-invasive) 
The recent development of the blood glucose monitoring 
device is more toward non-invasive method. This method is 
used to measure blood glucose levels in the human body by only 
placing the sensors directly to the human targeted area without 
drawing blood and insertion of needles or any types of 
biosensors as shown in Figure 7.  
The study on the development of this technology has begun 
since 1957 and the works are still continuing up to the present. 
Since 2014, only a few numbers of devices that have been 
produced using this technology and they are only available in 
certain countries as can be seen in Table 2 [3]. Most of the non-
invasive blood glucose monitoring device is registered under 
consumer product and not under a medical product because this 
device reads the value of the blood glucose without directly in 
contact with the blood. In the next section, the development of 
some of the available techniques of non-invasive glucose 
monitoring system are discussed. 
 
 




Development of non-invasive device [24- 26]. 
 
Device Description 
C8 MediSensors - 
Optical Glucose 
Monitor System 
 Technology used: Raman spectroscopy. 
 Target area: Skin 
 CE Mark approval (2011) 
 Available in certain countries 
 User characteristics: *pregnant  *smokes *not 





 Technology used: Thermal, ultrasound, 
electromagnetic. 
 Target area: Ear lobe 
 CE Mark approved (2013) 
 Available in certain countries (2014) 
 
OrSense NBM-200G 
(OrSense Ltd.)  
 Technology used: Occlusion NIR spectroscopy  
 Target area: Fingertip 
 CE Mark approved 
 
Echo Therapeutics – 
Continuous Glucose 
Monitor 
 Technology used: Advanced skin permeation 
technology (three different permeation 
technology) 
 Target area: Skin 
 
 
III. TECHNIQUES ON NON-INVASIVE BLOOD GLUCOSE 
MEASUREMENT 
 
These are a few different approaches of non-invasive blood 
glucose monitoring technique. As can be seen in Figure 8, these 
techniques can be divided into two different methods, which are 
the use of transdermal or optical methods. By using a non-
invasive method, it is an option for measuring the blood glucose 
level without any pain and no needle is involved [8]. This 
method uses an external sensor to indirectly track the blood 
glucose concentration, where the signal is recorded through the 
skin without imposing any damage  [14, 27, 28]. The glucose 
measurement can be done on the fluids produced by the body 
other than blood, such as tears, sweat, saliva or urine [6-18, 27, 
28]. However, continuous glucose monitoring using non-
invasive approach can only be achieved by using direct 
measurement to the body tissues such as skin, tympanic 
membrane, cornea, tongue or oral mucosa. By using a suitable 
transducer of blood glucose sensor, it is able to detect a weak 
signal indirectly from the blood through intervening tissues, 
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Figure 8: Non-invasive blood glucose measurement techniques. 
 
A. Transdermal 
i. Reverse Iontophoresis 
The physical energy is used by reverse iontophoresis to access 
the interstitial fluid. In between the two electrodes across the 
skin, there is a low current applied as shown in Figure 9 [8, 27]. 
This will cause charged and uncharged molecules to pass across 
the dermis at a rate significantly greater than the passive 
permeability, the ions move in the skin to maintain the 
neutrality. At physiological pH (~5.0-6.0), skin is negatively 
charged [27]. Therefore, a positively charged ion will penetrate 
more easily across the skin than a comparably sized negative 
ion.  
 
Figure 9: The basic concept of reverse Iontophoresis 
 
This technique has several potential advantages over other 
enzyme-based electrode sensor systems. An oxygen supply is 
not a bound factor to glucose oxides that can cause an increase  
to the concentration of glucose. However, this technique 
requires a long time to get it ready for calibration and it is 
complicated [26]. The first commercial device that uses this 
technique is GlucoWatch biographer monitor developed by 
Cygnus Inc. [21, 28, 29]. However, GlucoWatch still has some 
problems, such as it is not reliable to detect 
hypoglycaemia [30]. 
 
ii. Bio-impedance spectroscopy 
Bio-impedance spectroscopy method works by determining 
the dielectric properties of the skin tissue using two electrodes. 
As shown in Figure 10, the glucose concentration level in the 
body is determined by passing a small constant current at a 
fixed frequency between these electrodes and subsequently, 




Figure 10: The basic concept of Transdermal. 
 
The benefit of this method is the continuous nature of the 
measurement protocol (displayed the glucose level every 
minute), simple implementation and safety due to its non-
invasive nature. However, this technology requires a high cost 
and a prolonged calibration period of about 1 hour [6]. This 
technology has been introduced in 2000. The first device in the 
market that uses this technique is Pendra Glucose Monitoring 
by Pendragon Medical in 2003, while Echo Therapeutics is the 
latest device that has been introduced to use this technique in 
2011 [8, 26]. However, this device suffers serious inaccuracy 
limitations that could expose the user to potentially dangerous 
situations. The technique requires calibration and errors can 
occur due to variability, sweating and motion [27]. 
 
B. Optical 
Spectroscopic technique is an optical method used to detect 
blood glucose by determining the quantity of light which is 
either absorbed, transmitted or emitted as a function of glucose 
concentration [6, 27]. A small variation of the light after the 
light is passing through the target tissue will be detected by the 
sensor [31]. Based on that concept, there are a few techniques 
that use an optical method for the glucose detection as can be 





a) b) c) d) 
 
Figure 11: Diagram of different measurement configurations:                    
  a) Transflectance b) Transmission c) Diffuse reflectance and  
d) Photoacoustic. 
 
i. Near-infrared spectroscopy (NIR) 
NIR is based on the collection of tissue absorption or 
emission spectrum by diffused reflectance or transmission with 
a spectrometer as illustrated in Figure 12 [31]. This method 
utilizes light absorption or emission data with a wavelength 
between 700-2500 nm to detect the glucose in the blood glucose 
and Table 3 shows the characteristic of different wavelength 
region [33]. The absorption signature of water is less profound 
in this method, the signal related to glucose is weak compared 
to the MIR spectroscopy technology and powerful computer 
algorithms are required to interpret the sensor data [6, 14]. 






Near Infrared (NIR) Spectroscopy 





Thermal Emission Spectroscopy 
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transmission spectroscopy by using several different 
measurement sites, such as the cheeks, lip, tongue, nasal septum 
and tissue webbing and the results show that the tissue with less 
fat (tongue) provides spectrum with the highest signal to noise 
ratio [34].  
 
Table 3 
Characteristic of different wavelength region 
 
Wavelength (nm) Characteritics 
700-1300  Higher orders of glucose overtone regions 
 Little glucose absorption 
 Low light absorption of water 
 
1500-2500  Highest glucose absorption 
 Does not get effected by excessive water 
attenuation 
 Relative min. in water absorption spectrum 
 
 
There are many researchers who had conducted a study in this 
area by using NIR and they had suggested that this technique is 
capable to detect the signal of glucose in the blood because NIR 
has a suitable wavelength ranging from 700 nm–1500 nm [35], 
and it has a high energy of measuring signal compared to MIR 
[36]. NIR has been used due to its cheaper cost, sensitivity, 
complexity, probability and selectivity [37]. Ilan Gabriely et al. 
and H. Michael have done a research based on NIR by using a 
transcutaneous NIR spectroscopy system to monitor blood 
glucose levels during glycaemia and hypoglycaemia [38, 39]. 
The results proved that NIR can be used to predict the glucose 
levels in the human body. Kamboh and Khan had done an 
experiment on non-invasive blood glucose monitoring by using 
NIR spectroscopy to compare the accuracy with a conventional 
invasive technique [40]. In that study, they used LED 1550E 
from ThorLab as a light source and Indium Gallium Arsenide 
(InGaAs) photodiode as a light detector. This experiment was 
tested on 80 people and the result shows that there is a 
correlation between these two measurements with high signal-
noise-ratio (SNR) for glucose signals [36, 41]. 
The NIR technology for blood glucose monitoring has been 
used by Sensys Medical (USA), NIR diagnostics (Canada), 
Medicontract with Diabetic Trust (Germany) and Biocontrol 










ii. Mid-infrared spectroscopy (MIR) 
Similar to NIR, MIR is also based on light transmitting from 
the MIR transmitter through a skin tissue as can be seen in 
Figure 12.  The glucose concentration light can be measured 
from the signal that is not being absorbed and can be detected 
by detectors. This method utilizes light with wavelength in the 
range between 2.5 to 10 µm [43, 44]. However, this method has 
the main disadvantage, which is a limitation of the light path to 
penetrate into the tissue [27]. Moreover, the result signal has the 
presence of noise that affects other molecules such as water and 
other non-glucose metabolites which modulates the magnitude 
of the absorption peak of glucose light [6]. Technology MIR 
has been used in the European Union (EU) project called 
“Clinicip” to monitor the glucose concentration in intensive 
care units [6]. 
 
iii. Raman spectroscopy 
Raman spectroscopy applies a laser light of one wavelength, 
where the quantification and identification of blood glucose is 
judged by the changes in the frequency of the light that result 
from inelastic scattering of the oscillation and rotation motions 
in the glucose molecule [45, 46]. Figure 13 shows the basic 
concept on how Raman spectroscopy works for glucose 
detection. The advantage of Raman spectroscopy is that it has a 
high molecular specificity. It can reduce the interference of 
water compared to MIR or NIR spectroscopy due to weak 
diffusion index of water [28, 41]. However, the disadvantage of 
this technology is that it requires a laser radiation source. This 
can be dangerous to the cells because it may impend triggering 
photo thermal damage to the skin cells [28, 44]. Moreover, this 
technology requires a powerful detector and complicated 
instrumentation because of the detected signal is extremely 
weak causing the noise to be very visible after an interaction 




Figure 13: The basic concept of Raman spectroscopy. 
 
iv. Photoacoustic spectroscopy 
Photoacoustic spectroscopy utilizes waves of ultrasonic 
caused by the absorption of infrared light to measure the 
glucose concentration. The illustration of the Photoacoustic 
spectroscopy is shown in Figure 14. This method has the 
advantage of using optical radiation levels at several orders of 
magnitude below the threshold of pain or tissue damage as well 
as utilizing components that permit a compact portable sensor 
design to be made [48]. However, this technology suffers from 
the noise created from non-glucose blood components which 
needs to be excluded from the measurements [6]. 
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Figure 14: The basic concept of Photoacoustic spectroscopy. 
 
v. Polarimetry 
Polarimetry depends on the optical rotary dispersion of 
polarized light which means that all waves of light vibrate on 
the same plane [29, 49]. The rotation of the linear polarized 
light depends on some factors such as temperature, thickness 
and concentrations of the crossed sample [49, 50]. In the field 
of pharmaceutical and nutritional industries, this technology 
has been used since a long time ago to find out the level of the 
compounds in every mixture. However, the main target is not 
the skin tissues because high dispersion coefficient generates 
full beam depolarization [42]. This technology can be used to 
observe glucose from the aqueous humour of the eye which 
shows a minimal scattering and absorption effect and it interacts 
with the degree of rotation of the polarization vector that is 
proportional to the concentration of glucose. The use of 
complex multivariate calibrations can be bypassed using a 
single laser wavelength. This method has a weakness because 
it requires an external laser scanner which has to be accurately 
positioned in front of the eye and it is also sensitive towards 
variations of temperature and pH [50]. Additionally, this 
method also has a time lag for a few minutes before a change in 
the blood glucose concentration can be observed in the eye. 
This method has not yet undergone human trials due to safety 
limitation [28]. 
 
vi. Thermal emission spectroscopy 
 Thermal emission spectroscopy is based on the temperature 
variation measurement. By passing infrared (IR) signals 
through the human cell, the changes of the output signal 
generated from the IR is presented as changes in glucose 
concentration [27]. The light of IR radiation can be emitted by 
the human body and only specific wavelength can be permitted 
using a special filter for glucose measurement to pass to a 
detector [42]. The glucose concentration in blood  depends on 
the intensity of the wavelength specific to the radiation. 
However, this technology is also affected by a variation of body 
temperature and sensitive to the motion [27, 28]. The 
technology for glucose fingerprint uses the same concept as 
standard clinical tympanic membrane thermometers and it 
requires an additional specific wavelength of 9.8 µm and 





Non-invasive glucose monitoring devices have many 
advantages for diabetic patients. Since 1970, a lot of work have 
been done to improve the overall method of non-invasive 
glucose meter and monitoring systems. It is designed to be 
compact, wearable, lightweight and water resistant with 
advanced microelectronics chips that can be monitored by 
smartphones. Most of these devices are very expensive and 
categorised under consumer device.  
In general, all non-invasive optical glucose sensor technology 
suffers from human environmental factors such as body 
temperature, skin moisture, skin thickness and motion, which 
makes it difficult to be used due to the optical path of the 
excitation light. This technology also requires certain 
specifications of the user, given that the tissue composition and 
optical path length varies from one user to another. Because of 
that, glucose meter using strip is still very popular until now. 
The most common technology that has been widely studied 
is the NIR spectroscopy and MIR spectroscopy approaches. 
This is due to the reason that this method has a spectrum range 
with the ability to penetrate the light from 1-100 mm deep into 
the tissue as can be seen by the characteristics map in Table 3. 
Between these two technologies, NIR is claimed to be a better 
technique due to its cheaper cost, better sensitivity, complexity, 
selectivity, and better SNR. 
However, there are a few parameters such as temperature, 
skin thickness and skin colour that need to be focused and 
considered when using NIR spectroscopy technique since this 
will affect the measurement result. Therefore, improvements 
can be done by using a combination of various sensors to 
measure other parameters such as temperature and pulse 
sensors. Thus, the results will be considered in the algorithm 
development. 
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